Chicago- June 2024- GE HealthCare announced that it has named Roland Rott president and CEO of Imaging and Phil Rackliffe president and CEO of Ultrasound and Image Guided Therapies (IGT). Both leaders bring to their roles decades of deep experience in healthcare innovation and experience leading global teams in businesses of scale. This also highlights the depth of internal talent that GE HealthCare is building to strengthen focus on delivering for patients and customers. These changes will be effective July 1, 2024.

GE HealthCare will combine IGT, a $1.6 billion subsegment of Imaging, with the Ultrasound segment in the third quarter of 2024 to form a global business with more than $5.0 billion in annual revenue. GE HealthCare is aligning IGT with Ultrasound to better match its clinical usage and realize stronger business and customer impact by providing the right image guidance in the right care setting. Aligning IGT and Ultrasound positions GE HealthCare to be more agile and address future imaging needs using these real-time modalities in both inpatient and outpatient settings.

Also Read: GE HealthCare Names Adam Holton Chief People Officer

Without IGT, Imaging will remain GE HealthCare’s largest segment with more than $8.9 billion in annual revenue. This segment will enhance focus on solutions centered on surgical and interventional procedures, particularly interventional cardiology and structural heart, while continuing Ultrasound’s diagnostic leadership.

Peter Arduini, chief executive officer of GE HealthCare, said, “Roland and Phil will bring fresh viewpoints, global perspective, and deep industry expertise to our Imaging segment and new Ultrasound and IGT segment. Elevating leaders who have a deep understanding of our customers’ needs, market trends, and our strategic focus will help enable us to accelerate innovation and growth. Roland and Phil are proven leaders who are well positioned to take on these new opportunities, drive our precision care strategy, and deliver for patients and customers.”